E
China SXT Pharmaceuticals, Inc.
SXTC
$1.05
$0.021.94%
E
Sell
3/14/2023Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index.
D
Sell
3/6/2023Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 3/6/2023 due to a significant increase in the growth index and solvency index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 3/6/2023 due to a significant increase in the growth index and solvency index.
D
Sell
2/23/2023Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
D
Sell
1/12/2023Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 1/12/2023 due to an increase in the total return index and volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 1/12/2023 due to an increase in the total return index and volatility index.
E
Sell
12/28/2022Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 12/28/2022 due to a noticeable decline in the growth index, volatility index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 12/28/2022 due to a noticeable decline in the growth index, volatility index and total return index.
D
Sell
5/5/2022Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index and volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index and volatility index.
E
Sell
4/20/2022Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 4/20/2022 due to a decline in the solvency index, growth index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 4/20/2022 due to a decline in the solvency index, growth index and total return index.
D
Sell
11/30/2021Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 11/30/2021 due to a decline in the volatility index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 11/30/2021 due to a decline in the volatility index and total return index.
D
Sell
11/12/2021Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from E+ on 11/12/2021 due to an increase in the volatility index and valuation index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from E+ on 11/12/2021 due to an increase in the volatility index and valuation index.
E
Sell
11/8/2021Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and total return index.
D
Sell
11/5/2021Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 11/5/2021 due to an increase in the volatility index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 11/5/2021 due to an increase in the volatility index and total return index.
D
Sell
10/18/2021Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 10/18/2021 due to a decline in the volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 10/18/2021 due to a decline in the volatility index.
D
Sell
10/1/2021Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 10/1/2021 due to an increase in the volatility index, total return index and valuation index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 10/1/2021 due to an increase in the volatility index, total return index and valuation index.
D
Sell
9/13/2021Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 9/13/2021 due to a decline in the volatility index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 9/13/2021 due to a decline in the volatility index and total return index.
D
Sell
8/25/2021Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 8/25/2021 due to an increase in the valuation index, growth index and volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 8/25/2021 due to an increase in the valuation index, growth index and volatility index.
D
Sell
3/3/2021Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 3/3/2021 due to a decline in the valuation index and volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 3/3/2021 due to a decline in the valuation index and volatility index.
D
Sell
2/16/2021Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 2/16/2021 due to a noticeable increase in the volatility index, solvency index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 2/16/2021 due to a noticeable increase in the volatility index, solvency index and total return index.
D
Sell
12/21/2020Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 12/21/2020 due to an increase in the volatility index and total return index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 12/21/2020 due to an increase in the volatility index and total return index.
E
Sell
12/3/2020Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 12/3/2020 due to a decline in the volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 12/3/2020 due to a decline in the volatility index.
D
Sell
11/16/2020Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 11/16/2020 due to an increase in the volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 11/16/2020 due to an increase in the volatility index.
E
Sell
10/29/2020Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 10/29/2020 due to a decline in the volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 10/29/2020 due to a decline in the volatility index.
D
Sell
10/14/2020Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 10/14/2020 due to an increase in the volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E+ on 10/14/2020 due to an increase in the volatility index.
E
Sell
9/29/2020Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 9/29/2020 due to a decline in the volatility index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E+ from D- on 9/29/2020 due to a decline in the volatility index.
D
Sell
7/31/2020Downgrade
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 7/31/2020 due to a significant decline in the valuation index, efficiency index and growth index.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to D- from D on 7/31/2020 due to a significant decline in the valuation index, efficiency index and growth index.
D
Sell
2/4/2020Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 2/4/2020 due to a large increase in the valuation index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D from D- on 2/4/2020 due to a large increase in the valuation index.
D
Sell
10/1/2019Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E on 10/1/2019 due to a significant increase in the valuation index, growth index and solvency index.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to D- from E on 10/1/2019 due to a significant increase in the valuation index, growth index and solvency index.
E
Sell
7/1/2019Upgraded
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to E from E- on 07/01/2019.
China SXT Pharmaceuticals, Inc. (SXTC) was upgraded to E from E- on 07/01/2019.
E
Sell
6/21/2019None
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E- from U on 06/21/2019.
China SXT Pharmaceuticals, Inc. (SXTC) was downgraded to E- from U on 06/21/2019.
NASDAQ
04/26/2024 4:00PM Eastern
Quotes delayed
